1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ICOSAVAX INC

Icosavax Inc

XNAS: ICVX

Watchlist

Portfolio

Share


Insider Trading disclosures for Icosavax Inc

The latest disclosure was made by Simpson Adam in Icosavax Inc where a trade of 15,000 Common Stock done at an average price of $15.3 was reported to US exchanges on Jan. 30, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Simpson Adam Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.29 per share. 30 Jan 2024 15,000 358,657 - 15.3 229,386 Common Stock
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 30 Jan 2024 15,000 373,657 - 1.0 15,600 Common Stock
Adam Simpson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 30 Jan 2024 6,532 525,044 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2024 15,000 191,449 - - Stock Option (Right to Buy)
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2024 93,227 206,449 - - Stock Option (Right to Buy)
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 22 Jan 2024 4,789 265,430 - 0.8 4,023 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 22 Jan 2024 4,789 0 - - Stock Option (Right to Buy)
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 22 Jan 2024 93,227 358,657 - 1.0 96,956 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jan 2024 15,000 299,676 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 02 Jan 2024 15,000 275,641 - 1.0 15,600 Common Stock
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.67 per share. 02 Jan 2024 15,000 260,641 - 15.7 235,088 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 20 Dec 2023 23,343 350,641 - 0.8 19,608 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.47 per share. 20 Dec 2023 40,000 327,298 - 2.5 98,800 Common Stock
Simpson Adam Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.46 per share. 20 Dec 2023 62,205 184,724 - 15.5 961,509 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2023 102,574 314,676 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.46 per share. 20 Dec 2023 11,884 223,980 - 15.5 183,692 Common Stock
Simpson Adam Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.43 per share. 20 Dec 2023 40,000 260,641 - 15.4 617,060 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2023 23,343 4,789 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 15.46 per share. 20 Dec 2023 7,934 130,694 - 15.5 122,637 Common Stock
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 20 Dec 2023 102,574 287,298 - 1.0 106,677 Common Stock
Simpson Adam Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2023 40,000 237,146 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 15.44 per share. 20 Dec 2023 50,000 300,641 - 15.4 772,220 Common Stock
Cearley Cassia Chief Business Officer Sale of securities on an exchange or to another person at price $ 16.01 per share. 13 Dec 2023 8,759 131,200 - 16.0 140,190 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 01 Aug 2023 3,000 246,930 - 0.8 2,520 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Aug 2023 3,000 28,132 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jul 2023 11,788 243,930 - 8.9 104,459 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jul 2023 3,323 235,864 - 8.9 29,447 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 8.86 per share. 31 Jul 2023 1,888 139,959 - 8.9 16,731 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 9.59 per share. 03 Jul 2023 2,095 290,054 - 9.6 20,083 Common Stock
Douglas Holtzman Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2023 16,356 28,621 - - Stock Option (Right to Buy)
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 8.74 per share. 03 Jul 2023 14,261 292,149 - 8.7 124,660 Common Stock
Douglas Holtzman Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 03 Jul 2023 16,356 306,410 - 1.0 17,010 Common Stock
Mark D. Mcdade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
Heidi Kunz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
Ann M. Veneman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
John W. Shiver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,000 17,000 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 10.00 per share. 23 May 2023 10,000 141,847 - 10 100,000 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.08 per share. 03 Apr 2023 20,143 290,354 - 6.1 122,439 Common Stock
Douglas Holtzman Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Apr 2023 20,443 44,977 - - Stock Option (Right to Buy)
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.56 per share. 03 Apr 2023 300 290,054 - 6.6 1,968 Common Stock
Douglas Holtzman Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 03 Apr 2023 20,443 310,497 - 1.0 21,261 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 7.75 per share. 06 Mar 2023 5,000 151,847 - 7.7 38,737 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 15 Feb 2023 10,677 255,718 - 1.0 11,104 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Feb 2023 10,677 417,250 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 350,000 350,000 - - Stock Option (Right to Buy)
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 90,000 90,000 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 110,000 110,000 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 140,000 140,000 - - Stock Option (Right to Buy)
Elizabeth Bekiroglu General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Feb 2023 100,000 100,000 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 10.69 per share. 13 Feb 2023 7,506 245,041 - 10.7 80,259 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.17 per share. 13 Feb 2023 3,349 290,054 - 10.2 34,064 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 10.69 per share. 13 Feb 2023 1,522 293,403 - 10.7 16,274 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 10.69 per share. 13 Feb 2023 1,794 239,187 - 10.7 19,183 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 10.69 per share. 13 Feb 2023 1,660 156,847 - 10.7 17,750 Common Stock
Elizabeth Bekiroglu General Counsel & Corp. Sec. Sale of securities on an exchange or to another person at price $ 10.69 per share. 13 Feb 2023 5,922 103,007 - 10.7 63,322 Common Stock
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jan 2023 25,102 2,511 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 30 Jan 2023 25,102 156,840 - 0.8 21,086 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 25 Jan 2023 10,678 252,547 - 1.0 11,105 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 25 Jan 2023 2,395 241,869 - 0.8 2,012 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2023 10,678 427,927 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 25 Jan 2023 2,395 31,132 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2023 5,972 118,528 - - Stock Option (Right to Buy)
Kanesa-thasan Niranjan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. 04 Jan 2023 5,972 330,353 - 15 89,580 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 15.70 per share. 04 Jan 2023 106,373 223,980 - 15.7 1,670,460 Common Stock
Kanesa-thasan Niranjan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2023 11,947 108,369 - - Stock Option (Right to Buy)
Kanesa-thasan Niranjan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 04 Jan 2023 74,648 312,434 - 1.0 77,634 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 04 Jan 2023 13,806 237,786 - 0.8 11,597 Common Stock
Kanesa-thasan Niranjan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2023 13,806 2,511 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Jan 2023 74,648 42,193 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.90 per share. 04 Jan 2023 11,947 324,381 - 5.9 70,487 Common Stock
Adam Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 277,146 277,146 - - Stock Option (Right to Buy)
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 82,580 82,580 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 82,580 82,580 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 100,000 100,000 - - Stock Option (Right to Buy)
Elizabeth Bekiroglu General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Nov 2022 88,900 88,900 - - Stock Option (Right to Buy)
Elizabeth Bekiroglu General Counsel & Corp. Sec. Sale of securities on an exchange or to another person at price $ 4.87 per share. 08 Sep 2022 1,813 108,929 - 4.9 8,835 Common Stock
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.64 per share. 29 Jul 2022 7,017 293,772 - 6.6 46,575 Common Stock
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 6.70 per share. 29 Jul 2022 1,904 291,869 - 6.7 12,764 Common Stock
Adam Simpson Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 7.11 per share. 29 Jul 2022 2,456 300,789 - 7.1 17,456 Common Stock
Douglas Holtzman Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 29 Jul 2022 20,000 22,440 - 0 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 7.11 per share. 29 Jul 2022 585 303,048 - 7.1 4,158 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.64 per share. 29 Jul 2022 9,337 293,711 - 6.6 61,973 Common Stock
Douglas Holtzman Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 6.70 per share. 29 Jul 2022 453 293,258 - 6.7 3,037 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 6.70 per share. 29 Jul 2022 543 239,314 - 6.7 3,640 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 6.64 per share. 29 Jul 2022 2,001 239,857 - 6.6 13,281 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Sale of securities on an exchange or to another person at price $ 7.11 per share. 29 Jul 2022 701 241,858 - 7.1 4,982 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 6.64 per share. 29 Jul 2022 1,118 132,041 - 6.6 7,421 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 6.70 per share. 29 Jul 2022 303 131,738 - 6.7 2,031 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 7.11 per share. 29 Jul 2022 391 133,159 - 7.1 2,779 Common Stock
Charles Richardson SVP, Technical Operations Sale of securities on an exchange or to another person at price $ 6.70 per share. 29 Jul 2022 371 165,168 - 6.7 2,487 Common Stock
Charles Richardson SVP, Technical Operations Sale of securities on an exchange or to another person at price $ 7.11 per share. 29 Jul 2022 479 166,907 - 7.1 3,405 Common Stock
Charles Richardson SVP, Technical Operations Sale of securities on an exchange or to another person at price $ 6.64 per share. 29 Jul 2022 1,368 165,539 - 6.6 9,080 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2022 7,185 47,896 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 01 Jul 2022 7,185 303,245 - 0.8 6,035 Common Stock
Mark D. Mcdade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 5,543 55,786 - 0 Common Stock
Mark D. Mcdade Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 22,278 22,278 - - Stock Option (Right to Buy)
Heidi Kunz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 22,278 22,278 - - Stock Option (Right to Buy))
Heidi Kunz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 5,543 14,293 - 0 Common Stock
Ann M. Veneman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 5,543 14,043 - 0 Common Stock
Ann M. Veneman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 22,278 22,278 - - Stock Option (Right to Buy)
John W. Shiver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 2,399 10,899 - 0 Common Stock
John W. Shiver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2022 9,643 9,643 - - Stock Option (Right to Buy)
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 5.77 per share. 31 May 2022 1,667 294,925 - 5.8 9,619 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 5.77 per share. 31 May 2022 1,667 240,981 - 5.8 9,619 Common Stock
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 5.77 per share. 31 May 2022 1,667 158,507 - 5.8 9,619 Common Stock
Mark D. Mcdade Director Purchase of securities on an exchange or from another person at price $ 7.10 per share. 01 Apr 2022 42,225 50,243 - 7.1 299,798 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Mar 2022 4,789 55,081 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 28 Mar 2022 4,789 220,482 - 0.8 4,023 Common Stock
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 18 Mar 2022 35,137 133,550 - 0.8 29,515 Common Stock
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2022 35,137 27,613 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 17.13 per share. 07 Mar 2022 9,516 98,897 - 17.1 163,009 Common Stock
Cassia Cearley Chief Business Officer Sale of securities on an exchange or to another person at price $ 17.81 per share. 07 Mar 2022 484 98,413 - 17.8 8,620 Common Stock
Charles Richardson SVP, Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 14 Feb 2022 66,375 161,200 - 0.8 55,755 Common Stock
Charles Richardson SVP, Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2022 66,375 43,489 - - Stock Option (Right to Buy)
Charles Richardson SVP, Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Feb 2022 6,186 16,657 - - Stock Option (Right to Buy)
Charles Richardson SVP, Technical Operations Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 14 Feb 2022 6,186 167,386 - 1.0 6,433 Common Stock
Adam Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 317,866 317,866 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 75,578 291,271 - 0 Common Stock
Douglas Holtzman Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 10 Feb 2022 10,000 42,440 - 0 Common Stock
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 19,485 303,633 - 0 Common Stock
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 81,950 81,950 - - Stock Option (Right to Buy)
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 81,950 81,950 - - Stock Option
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 19,485 242,559 - 0 Common Stock
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 21,256 108,413 - 0 Common Stock
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 89,400 89,400 - - Stock Option (Right to Buy)
Charles Richardson SVP, Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 15,942 94,825 - 0 Common Stock
Charles Richardson SVP, Technical Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 67,050 67,050 - - Stock Option (Right to Buy)
Elizabeth Bekiroglu General Counsel & Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2022 82,992 110,742 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 26 Jan 2022 125,000 531,576 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2022 73,929 438,605 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Jan 2022 16,764 59,870 - - Stock Option (Right to Buy)
Adam Simpson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 26 Jan 2022 125,000 129,032 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 26 Jan 2022 125,000 129,032 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Gift of securities by or to the insider at price $ 0.00 per share. 26 Jan 2022 125,000 656,576 - 0 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. 26 Jan 2022 73,929 215,693 - 1.0 76,886 Common Stock
Adam Simpson Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.84 per share. 26 Jan 2022 16,764 141,764 - 0.8 14,082 Common Stock
John W. Shiver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 25,500 25,500 - - Stock Option (Right to Buy)
John W. Shiver Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 8,500 8,500 - 0 Common Stock
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Nov 2021 22,598 62,750 - - Stock Option (Right to Buy)
Cassia Cearley Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.83 per share. 15 Nov 2021 22,598 85,491 - 0.8 18,756 Common Stock
Elisha P. Gould Director 02 Aug 2021 114,843 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Aug 2021 12,368 256,783 - 15 185,520 Common Stock
Elisha P. Gould Director 02 Aug 2021 244,415 244,415 - 0 Common Stock
Elisha P. Gould Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Aug 2021 26,604 552,333 - 15 399,060 Common Stock
Elisha P. Gould Director 02 Aug 2021 525,729 525,729 - 0 Common Stock
Elisha P. Gould Director 02 Aug 2021 352,037 352,037 - 0 Common Stock
Elisha P. Gould Director 02 Aug 2021 272,131 272,131 - 0 Common Stock
Elisha P. Gould Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Aug 2021 46,381 962,939 - 15 695,715 Common Stock
Elisha P. Gould Director 02 Aug 2021 916,558 916,558 - 0 Common Stock
Elisha P. Gould Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 02 Aug 2021 47,981 996,169 - 15 719,715 Common Stock
Elisha P. Gould Director 02 Aug 2021 948,188 948,188 - 0 Common Stock
Elisha P. Gould Director 02 Aug 2021 79,734 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 171,505 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 88,775 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 299,003 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 309,321 0 - - Series B-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 935,985 0 - - Series A-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 2,013,269 0 - - Series A-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 1,348,119 0 - - Series A-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 1,042,120 0 - - Series A-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 3,509,939 0 - - Series A-1 Preferred Stock
Elisha P. Gould Director 02 Aug 2021 3,631,066 0 - - Series A-1 Preferred Stock
Heidi Kunz Director Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 8,750 8,750 - 15 131,250 Common Stock
Ann M. Veneman Director Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 8,500 8,500 - 15 127,500 Common Stock
Adam Simpson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 125,000 125,000 - 15 1,875,000 Common Stock
Douglas Holtzman Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 41,500 282,482 - 15 622,500 Common Stock
Douglas Holtzman Chief Scientific Officer 30 Jul 2021 52,440 52,440 - 0 Common Stock
Douglas Holtzman Chief Scientific Officer 30 Jul 2021 206,323 0 - - Series A-1 Preferred Stock
Douglas Holtzman Chief Scientific Officer 30 Jul 2021 11,602 0 - - Series B-1 Preferred Stock
Niranjan Kanesa-thasan Chief Medical Officer Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 41,500 168,656 - 15 622,500 Common Stock
Niranjan Kanesa-thasan Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 15.00 per share. 30 Jul 2021 6,666 6,666 - 15 99,990 Common Stock
Cassia Cearley Chief Business Officer Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 27,750 62,893 - 15 416,250 Common Stock
Charles Richardson See Remarks Grant, award, or other acquisition of securities at price $ 15.00 per share. 30 Jul 2021 27,750 78,883 - 15 416,250 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters